Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (7): 700-704.DOI: 10.3969/j.issn.1673-8640.2026.07.014
Previous Articles Next Articles
Received:2024-09-06
Revised:2025-07-09
Online:2026-07-30
Published:2026-07-23
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.07.014
| 首发症状 | 例数 | 百分比/% |
|---|---|---|
| 发热伴 | ||
| 呼吸道症状 | 10 | 20 |
| 单纯性发热 | 9 | 18 |
| 关节疼痛 | 7 | 14 |
| 胃肠道症状 | 4 | 8 |
| 乏力、纳差 | 5 | 10 |
| 非发热伴 | ||
| 关节疼痛 | 9 | 18 |
| 乏力、纳差 | 4 | 8 |
| 胃肠道症状 | 2 | 4 |
| 首发症状 | 例数 | 百分比/% |
|---|---|---|
| 发热伴 | ||
| 呼吸道症状 | 10 | 20 |
| 单纯性发热 | 9 | 18 |
| 关节疼痛 | 7 | 14 |
| 胃肠道症状 | 4 | 8 |
| 乏力、纳差 | 5 | 10 |
| 非发热伴 | ||
| 关节疼痛 | 9 | 18 |
| 乏力、纳差 | 4 | 8 |
| 胃肠道症状 | 2 | 4 |
| 项目 | 例数 | 百分比/% |
|---|---|---|
| 虎红平板凝集试验阳性 | 50 | 100 |
| 试管凝集试验阳性 | ||
| 1∶100~1∶200 | 12 | 24 |
| 1∶400~1∶800 | 29 | 58 |
| >1∶800 | 9 | 18 |
| CRP>10 mg·L-1 | 41 | 82 |
| ESR>15 mm·h-1 | 30 | 60 |
| ALT>40 U·L-1 | 19 | 38 |
| AST>40 U·L-1 | 15 | 30 |
| PCT>0.5 ng·mL-1 | 7 | 14 |
| WBC计数>9.5×109L-1 | 4 | 8 |
| Alb<40 g·L-1 | 33 | 66 |
| Hb(男性<130 g·L-1,女性<115 g·L-1) | 29 | 58 |
| TP<65 g·L-1 | 20 | 40 |
| PLT计数<115×109L-1 | 12 | 24 |
| 项目 | 例数 | 百分比/% |
|---|---|---|
| 虎红平板凝集试验阳性 | 50 | 100 |
| 试管凝集试验阳性 | ||
| 1∶100~1∶200 | 12 | 24 |
| 1∶400~1∶800 | 29 | 58 |
| >1∶800 | 9 | 18 |
| CRP>10 mg·L-1 | 41 | 82 |
| ESR>15 mm·h-1 | 30 | 60 |
| ALT>40 U·L-1 | 19 | 38 |
| AST>40 U·L-1 | 15 | 30 |
| PCT>0.5 ng·mL-1 | 7 | 14 |
| WBC计数>9.5×109L-1 | 4 | 8 |
| Alb<40 g·L-1 | 33 | 66 |
| Hb(男性<130 g·L-1,女性<115 g·L-1) | 29 | 58 |
| TP<65 g·L-1 | 20 | 40 |
| PLT计数<115×109L-1 | 12 | 24 |
| 项目 | A组 | B组 | P值 |
|---|---|---|---|
| CRP | 28.90(16.68,60.56) | 2.65(0.9,11.2) | <0.001 |
| ESR | 19.50(15.00,32.00) | 12.00(7.75,19.00) | <0.001 |
| Alb | 35.30(32.70,41.90) | 42.00(38.20,45.00) | <0.001 |
| 项目 | A组 | B组 | P值 |
|---|---|---|---|
| CRP | 28.90(16.68,60.56) | 2.65(0.9,11.2) | <0.001 |
| ESR | 19.50(15.00,32.00) | 12.00(7.75,19.00) | <0.001 |
| Alb | 35.30(32.70,41.90) | 42.00(38.20,45.00) | <0.001 |
| 项目 | AUC(95%CI①) | P值 | 敏感性/% | 特异性/% |
|---|---|---|---|---|
| CRP | 0.888(0.825~0.951) | 0.00 | 0.82 | 0.72 |
| Alb | 0.738(0.644~0.838) | 0.00 | 0.54 | 0.88 |
| ESR | 0.726(0.627~0.824) | 0.00 | 0.78 | 0.56 |
| 3项指标联合 | 0.878(0.808~0.942) | 0.00 | 0.72 | 0.92 |
| 项目 | AUC(95%CI①) | P值 | 敏感性/% | 特异性/% |
|---|---|---|---|---|
| CRP | 0.888(0.825~0.951) | 0.00 | 0.82 | 0.72 |
| Alb | 0.738(0.644~0.838) | 0.00 | 0.54 | 0.88 |
| ESR | 0.726(0.627~0.824) | 0.00 | 0.78 | 0.56 |
| 3项指标联合 | 0.878(0.808~0.942) | 0.00 | 0.72 | 0.92 |
| [1] | 张晶, 王占黎, 李星男, 等. 人类布鲁氏菌病流行病学研究进展[J]. 中国感染控制杂志, 2023, 22(2):239-243. |
| [2] | 布鲁氏菌病诊疗方案(2023年版)[J]. 中国感染控制杂志, 2024, 23(5):661-664. |
| [3] | 王太武, 韩一芳, 曹勇平, 等. 2005—2020年我国布鲁菌病发病率年龄时期队列分析及趋势预测[J]. 中国预防医学杂志, 2024, 25(11):1382-1387. |
| [4] |
Guo X, Zeng H, Li M, et al. The mechanism of chronic intracellular infection with Brucella spp[J]. Front Cell Infect Microbiol, 2023, 13:1129172.
DOI URL |
| [5] |
Qiangsheng F, Xiaoqin H, Tong L, et al. Brucella cultures characteristics,clinical characteristics,and infection biomarkers of human brucellosis[J]. J Infect Public Health, 2023, 16(3):303-309.
DOI URL |
| [6] |
Spernovasilis N, Karantanas A, Markaki I, et al. Brucella spondylitis:current knowledge and recent advances[J]. J Clin Med, 2024, 13(2):595.
DOI URL |
| [7] | 李钊, 张友文, 姜鲁宁. 72例布鲁菌病患者临床特征分析[J]. 中华地方病学杂志, 2018, 37(10):822-825. |
| [8] |
Li L M, Wang Q, Shi J F, et al. Seroprevalence and potential risk factors of brucellosis in sheep from America,Africa and Asia regions:a systematic review and meta-analysis[J]. Res Vet Sci, 2023, 165:105048.
DOI URL |
| [9] | 王莹, 郭伟泉, 向媛媛, 等. 2004—2015年甘肃省人间布鲁氏菌病与气象因素的相关性[J]. 中国动物检疫, 2022, 39(1):18-22. |
| [10] | 郭珂宇, 关鹏, 单连峰, 等. 2013至2021年我国人布鲁氏菌病发病重心轨迹特征分析[J]. 中国医科大学学报, 2023, 52(8):680-683. |
| [11] | Buzgan T, Karahocagil M K, Irmak H, et al. Clinical manifestations and complications in 1 028 cases of brucellosis:a retrospective evaluation and review of the literature[J]. Int J Infect Dis, 2010, 14(6):e469-e478. |
| [12] |
Bzeizi K I, Benmousa A, Sanai F M. Coincidence of acute Brucella hepatitis and dengue fever or serologic cross-reactivity?[J]. Saudi J Gastroenterol, 2010, 16(4):299-301.
DOI URL |
| [13] |
吴志国, 徐慧丽, 罗小露, 等. 布鲁菌病35例临床特征分析[J]. 中国感染与化疗杂志, 2021, 21(2):181-184.
DOI |
| [14] | 赵旭春, 刘颖翰, 王玮, 等. 125例成人急性布鲁氏菌病患者的肝功能异常临床分析[J]. 中国地方病防治, 2010, 25(1):68-69. |
| [15] | 贾斌, 张峰波, 朱玥洁, 等. 血液检出布鲁氏菌阳性患者的实验室及临床特点分析[J]. 新疆医科大学学报, 2017, 40(2):136-140. |
| [16] | 宋仕玲, 祝捷, 曾芙蓉, 等. 深圳市39例急性期布鲁菌病患者临床特征分析[J]. 中华地方病学杂志, 2019, 38(9):739-742. |
| [17] | 李华, 张志伟, 高晓娟, 等. 河南省99例布鲁菌病患者临床特征分析[J]. 中华地方病学杂志, 2018, 37(5):402-405. |
| [18] |
Liu J, Zhao X. Clinical features and serum profile of inflammatory biomarkers in patients with brucellosis[J]. J Infect Dev Ctries, 2017, 11(11):840-846.
DOI URL |
| [19] | Xu N, Dong X, Yao Y, et al. Improved early detection of focal brucellosis complications with anti-Brucella IgG[J]. J Clin Microbiol, 2020, 58(10):e00903-20. |
| [20] |
Yetkin M A, Erdinc F S, Bulut C, et al. Epididymoorchitis due to brucellosis in central Anatolia,Turkey[J]. Urol Int, 2005, 75(3):235-238.
DOI URL |
| [1] | GAO Hongzhi, CAO Jinnan, HUANG Shenglei, ZHOU Chunmei, ZHOU Jiaye, WANG Beili, PAN Baishen, GUO Wei. In vitro antibacterial activity of sulbactam/durlobactam and eravacycline against Acinetobacter [J]. Laboratory Medicine, 2026, 41(7): 637-642. |
| [2] | GUO Changcheng, YANG Kun, ZHAO Xiaoqin, JIA Liping, LI Yan. Construction of risk prediction model of secondary bloodstream infection of ICU patients based on machine learning algorithm [J]. Laboratory Medicine, 2026, 41(5): 476-482. |
| [3] | . [J]. Laboratory Medicine, 2026, 41(3): 282-286. |
| [4] | . [J]. Laboratory Medicine, 2026, 41(2): 193-195. |
| [5] | LI Li, DU Jinye, WANG Xinyi, DAI Jing. Risk factors,drug resistance and virulence analysis of Klebsiella pneumoniae bloodstream infection [J]. Laboratory Medicine, 2025, 40(9): 885-891. |
| [6] | . [J]. Laboratory Medicine, 2025, 40(9): 907-913. |
| [7] | WU Xiaoqiong, CHEN Dongmiao, LIANG Yumin, WANG Congrong. Influence of Helicobacter pylori Ⅰ and Ⅱ infection on chronic gastritis [J]. Laboratory Medicine, 2025, 40(8): 798-803. |
| [8] | WANG Yali, CHEN Zongyao, ZHENG Mao, XU Dan, GUO Jiniuniu. Clinical characteristics and prognostic factors of patients with carbapenem-resistant hypervirulent Klebsiella pneumoniae infection [J]. Laboratory Medicine, 2025, 40(7): 693-697. |
| [9] | . [J]. Laboratory Medicine, 2025, 40(5): 508-511. |
| [10] | . [J]. Laboratory Medicine, 2025, 40(1): 102-104. |
| [11] | GUO Chaonan, WANG Yanyan, ZHANG Bei, PANG Jingying, CUI Feifei, ZHAO Yongxin, SU Bing. Analysis of drug resistance and virulence of Klebsiella pneumoniae from different clinical samples [J]. Laboratory Medicine, 2024, 39(9): 880-887. |
| [12] | CAI Min, ZHANG Hui. Research progress for CRE infection in intensive care unit patients [J]. Laboratory Medicine, 2024, 39(9): 913-918. |
| [13] | HUANG Linling, XU Meirong, SHEN Xiaowen, GU LingLi, SHEN Hongmei. Changes and significance of autophagy in peripheral blood lymphocytes of patients with carbapenem-resistant Enterobacteriaceae-bloodstream infection [J]. Laboratory Medicine, 2024, 39(8): 759-763. |
| [14] | WU Xinzhe, MAO Haifeng, YANG Jin, ZUO Chunlei, JIN Danting. Clinical application of MALDI-TOF direct droplet culture method in rapid determination of CRKP [J]. Laboratory Medicine, 2024, 39(6): 587-591. |
| [15] | SUN Miaoli, WU Qiong, WANG Yingzhi, WANG Jianqiang, GAO Feng, TANG Jin. Research progress on determination and treatment of carbapenem-resistant Klebsiella pneumoniae [J]. Laboratory Medicine, 2024, 39(6): 615-620. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||